Wholesale of pharmaceutical and medical goods
FRESENIUS KABI NORGE AS
Revenue 2024
NOK 1.3bn
Operating profit
NOK 78.5m
Equity
NOK 651.4m
Incorporated
1998
Employees
28
Share capital
NOK 50.7m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 1.3bn | |
| Total operating costs | 1.2bn | |
| Operating profit (EBIT) | 78.5m | |
| Net financial items | 10.7m | |
| Profit for the year | 66.3m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 1.8bn | |
| of which current assets | 1.2bn | |
| Equity | 651.4m | |
| Total liabilities | 1.2bn |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.